NovaBay Pharmaceuticals Inc. (AMEX:NBY) shares traded higher over the last trading session, gaining 11.81% on 02/22/21. The shares fell to a low of $1.23 before closing at $1.42. Intraday shares traded counted 23.44 million, which was -445.1% lower than its 30-day average trading volume of 4.30M. NBY’s previous close was $1.27 while the outstanding shares total 40.04M. The firm has a beta of 3.85. The stock’s Relative Strength Index (RSI) is 68.57, with weekly volatility at 27.67% and ATR at 0.19. The NBY stock’s 52-week price range has touched low of $0.24 and a $1.94 high.
Investors have identified the Biotechnology company NovaBay Pharmaceuticals Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $66.75 million, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
NovaBay Pharmaceuticals Inc. (NBY) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. In terms of their assets, the company currently has 16.01 million total, with 3.0 million as their total liabilities.
Having a look at the company’s valuation, the company is expected to record -0.09 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on NBY sounds very interesting.
Is the stock of NBY attractive?
In related news, Director, WU MIJIA sold 20,000 shares of the company’s stock in a transaction that recorded on Aug 17. The sale was performed at an average price of 1.35, for a total value of 27,000. As the sale deal closes, the 10% Owner, Fu Jian Ping now sold 1,302,350 shares of the company’s stock, valued at 1,601,891. In the last 6 months, insiders have changed their ownership in shares of company stock by 25.21%.